-Ruchita Karmakar, Amity University Kolkata
A research team led by Debojyoti Chakraborty and Souvik Maiti of CSIR and TATA group came up with a new test named FELUDA to detect COVID-19. It’s a paper test strip that gives a precise result within 30 minutes; Approved for commercial launch by the Drugs Controller General of India.
FNCAS9 Editor Linked Uniform Detection Assay (FELUDA) uses the earliest developmental process of CRISPR gene-editing technology to detect the targeted genetic material of SARS-CoV2 that radially causes COVID-19. According to CSIR, this particular test equally works like that of the RT-PCR test.
The FELUDA rapid test strip is very much similar to the pregnancy test strip that changes color on detection. As per the researcher Dr. Debojyoti Chakraborty, the Cas9 protein is encrypted to interact with the SARS-CoV2 sequence in the host’s genetic material. The cas9-SARS-CoV2 complex is then pitted on the strip to detect whether the patient is positive for COVID-19 or otherwise.
A nominal cost of Rs.500 will grant an edge to detect COVID-19 in the best possible way.
For more updates : https://bioxone.in//
CIPA- a rare insensitivity
Ankita Chattopadhyay, Amity University Kolkata CIPA refers to a rare hereditary disease-Congenital insensitivity to pain and anhydrosis. This name is very descriptive as it reveals several important characters of the disease itself and is also called hereditary sensory and autonomic neuropathy type IV (HSAN-IV) and is a nerve disease that targets the nerves controlling sensation. […]